LaSalle Street Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

LaSalle Street Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$4.62M	Sell	15,844 -130	-0.8%	-$37.2K	5.35%	2
2019 Q2	$4.69M	Hold	15,974	–	–	5.49%	2
2019 Q1	$4.37M	Sell	15,974 -106	-0.7%	-$26.4K	5.15%	2
2018 Q4	$3.6M	Sell	16,080 -810	-5%	-$190K	5.17%	1
2018 Q3	$4.12M	Sell	16,890 -1,852	-10%	-$426K	4.82%	1
2018 Q2	$3.88M	Sell	18,742 -4,093	-18%	-$869K	3.86%	1
2018 Q1	$4.71M	Sell	22,835 -3,112	-12%	-$653K	3.73%	2
2017 Q4	$4.93M	Buy	25,947 +712	+3%	+$136K	3.4%	4
2017 Q3	$4.77M	Hold	25,235	–	–	3.51%	2
2017 Q2	$4.4M	Hold	25,235	–	–	3.59%	5
2017 Q1	$3.88M	Sell	25,235 -115	-0.5%	-$17.6K	3.23%	4
2016 Q4	$3.58M	Hold	25,350	–	–	3.18%	5
2016 Q3	$4.03M	Hold	25,350	–	–	3.73%	3
2016 Q2	$3.75M	Hold	25,350	–	–	3.58%	3
2016 Q1	$3.59M	Sell	25,350 -394	-2%	-$52.8K	3.52%	5
2015 Q4	$3.65M	Sell	25,744 -606	-2%	-$80.8K	3.62%	4
2015 Q3	$3.22M	Hold	26,350	–	–	3.42%	4
2015 Q2	$3.42M	Hold	26,350	–	–	3.33%	4
2015 Q1	$3.54M	Hold	26,350	–	–	3.48%	4
2014 Q4	$3.3M	Buy	+26,350	New	+$3.2M	3.23%	4

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LaSalle Street Capital Management's TMO Position: Q3 2019 in Review

LaSalle Street Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 0.81% in Q3 2019, selling an estimated $37.2K and leaving 15,844 shares worth $4.62M. The position accounts for 5.35% of the portfolio, ranked #2.

LaSalle Street Capital Management first reported a position in TMO in Q4 2014 and has held it in 20 quarters since. The position peaked at $4.93M in Q4 2017. 1,544 funds tracked by Wall St. Rank hold TMO as of Q3 2019.

LaSalle Street Capital Management held 15,844 shares of Thermo Fisher Scientific worth $4.62M as of Q3 2019.
LaSalle Street Capital Management sold 130 Thermo Fisher Scientific shares in Q3 2019, an estimated $37.2K.
Thermo Fisher Scientific made up 5.35% of LaSalle Street Capital Management's portfolio in Q3 2019, its #2 holding.
LaSalle Street Capital Management first reported a position in Thermo Fisher Scientific in Q4 2014 and has held it in 20 quarters since.
LaSalle Street Capital Management's Thermo Fisher Scientific position peaked at $4.93M in Q4 2017.
1,544 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2019.

Based on LaSalle Street Capital Management's 13F filing for Q3 2019, filed 28 Oct 2019.